# Narayana Hrudayalaya (NH) — Stock analysis

> Faxioms all-in-one stock review. Canonical page: https://faxioms.com/stocks/nh

## Current market snapshot

- Exchange: NSE
- Country: India
- Price: ₹1,902.1
- Change: -0.70%
- As of: 2026-11-06
- 1D return: -0.70%
- 5D return: +10.57%
- 1M return: +12.20%
- Latest complete quarter: fy27_q2

## Faxioms Analysis

_As of 2026-11-06_

### Technical Outlook

NH is trading at ₹1902.1 on 2026-11-06, positioned near the upper end of its recent ranges (+84.6% in the 20-day and 50-day bands). The daily trend is established and bullish, with price holding above all key moving averages and the Supertrend indicator (ADX 31.6). However, this short-term strength contrasts with a bearish monthly Supertrend and a significant downward weekly gap on 2026-11-06 that widened the range by 11.5%. While momentum indicators like +DI (31.52) exceed -DI (16.17) on the daily chart, the stock remains in a notable drawdown (-16.0% from highs) with high volatility (32.2% annualized). Immediate resistance lies at ₹1926.1 (pivot), while support is tight at ₹1899.3. The setup suggests a battle between daily bullishness and longer-term structural pressure.

- Daily trend is bullish (price above EMA/SMA/Supertrend; ADX 31.6), but monthly Supertrend remains bearish, indicating timeframe conflict.
- A high-severity downward weekly gap occurred on 2026-11-06, adding volatility and signaling potential distribution despite daily gains.
- Price is near multi-period highs (+84.6% in 20/50-day ranges); immediate resistance at ₹1926.1, support at ₹1899.3.
- Stock trades at a -16.0% drawdown with 32.2% annualized volatility; YTD return is negative (-1.7%) despite strong 1-month performance (+10.3%).

- Inside Bar
- Doji
- Harami
- Morning Star

### News Context

On November 3, 2026, broker Prabhudas Lilladher issued a 'Buy' recommendation for Narayana Hrudayalaya (NH), setting a price target of ₹2,350. This rating was reported by Moneycontrol as part of its stock market coverage. The analyst action represents an external opinion on the stock's valuation and potential upside rather than a corporate announcement or operational update from NH itself.

- Prabhudas Lilladher assigned a 'Buy' rating to Narayana Hrudayalaya on November 3, 2026.
- The broker set a specific price target of ₹2,350 for the stock.
- This development reflects third-party analyst sentiment and does not indicate new company-specific operational events.

- [Buy Narayana Hrudayalaya; target of Rs 2350: Prabhudas Lilladher](https://www.moneycontrol.com/news/business/stocks/buy-narayana-hrudayalaya-target-of-rs-2350-prabhudas-lilladher-2-14067611.html)

### What Changed

On November 5, 2026, Narayana Hrudayalaya Ltd. (NH) announced that its Founder and Chairman, Dr. Devi Prasad Shetty, was conferred the French National Order of Merit (Knight rank). The recognition, awarded by the French Republic in Bengaluru, cited his leadership and NH’s support for the French community during the COVID-19 pandemic, specifically regarding vaccination programs and essential logistics. This is a reputational milestone highlighting international recognition of the company's healthcare contributions.

Market data as of November 6, 2026, shows NH trading at ₹1,902.10, down from the previous close of ₹1,915.50. No daily or weekly trend indicators are currently available to assess broader market momentum alongside this announcement.

- November 5, 2026: Founder Dr. Devi Prasad Shetty received the French National Order of Merit (Knight rank) for pandemic-era support to the French community in Bengaluru.
- November 6, 2026 closing price: ₹1,902.10, reflecting a decline from the prior close of ₹1,915.50.
- Reputational signal: International award underscores global standing of NH’s healthcare initiatives, though no direct financial impact metrics are disclosed.

- [Narayana Hrudayalaya Ltd. has informed the Exchange regarding 'Conferment of the French National Order of Merit on Dr. Devi Prasad Shetty, Founder and Chairman'. |SUBJECT: Updates](https://nsearchives.nseindia.com/corporate/Narayana_05112026202146_SENHLRecognition_to_DrShetty_05112026.pdf)

### Official Filings

Narayana Hrudayalaya Ltd. (NH) reported Q2 FY27 results showing consolidated operating revenue of ₹28,440 Mn (+73.0% YoY) and PAT of ₹3,012 Mn (+16.6% YoY), with growth largely attributed to its UK acquisition. The company maintains a net debt position of ₹18,830 Mn against a net debt-to-equity ratio of 0.38. Operationally, NH commenced the Banashankari Hospital and Nagarabhavi Clinic in late September 2026 and is pursuing capacity expansion adding 5,400 beds across Bangalore and Kolkata at an estimated cost of ₹18,500 Mn. On the corporate action front, the NCLT Bengaluru Bench approved the demerger of clinical services from wholly owned subsidiary NH Integrated Care Private Limited into the parent, effective April 1, 2025, with no change to share capital or holding patterns. Additionally, the proposed merger with Meridian Medical Research & Hospital Ltd. has received regulatory no-objection letters and awaits a final NCLT order.

- Q2 FY27 Consolidated Operating Revenue: ₹28,440 Mn (+73.0% YoY); PAT: ₹3,012 Mn (+16.6% YoY).
- Balance Sheet: Net Debt stands at ₹18,830 Mn with a net debt-to-equity ratio of 0.38.
- Corporate Restructuring: NCLT approved demerger of clinical services from NH Integrated Care Private Limited; Meridian Medical Research & Hospital Ltd. merger awaits final NCLT order.
- Expansion Pipeline: Projected addition of 5,400 beds in Bangalore and Kolkata with total project costs of ₹18,500 Mn.

- [Narayana Hrudayalaya Ltd. has informed the Exchange regarding 'Conferment of the French National Order of Merit on Dr. Devi Prasad Shetty, Founder and Chairman'. |SUBJECT: Updates](https://nsearchives.nseindia.com/corporate/Narayana_05112026202146_SENHLRecognition_to_DrShetty_05112026.pdf)
- [Narayana Hrudayalaya Ltd. has informed the Exchange about Filing of the Orderof the Hon ble National Company Law Tribunal, Bengaluru Bench sanctioning the Scheme ofArrangement between NH Integrated Care Private Limited (WOS) and NarayanaHrudayalaya Limited |SUBJECT: Demerger](https://nsearchives.nseindia.com/corporate/Narayana_04112026222839_SE-Order_-NHIC_Demerger.pdf)
- [Narayana Hrudayalaya Ltd. has informed the Exchange about Schedule of Analysts or Institutional Investors Meet |SUBJECT: Analyst/Investor Meet Para A-XBRL](https://nsearchives.nseindia.com/corporate/xbrl/SAIIM_13340_WebXMLFile_20261103_121255291.xml)
- [Narayana Hrudayalaya Ltd. has informed the Exchange about Audio Recording/Video Recording |SUBJECT: Analyst/Investor Meet Para A-XBRL](https://nsearchives.nseindia.com/corporate/xbrl/SAIIM_13340_WebXMLFile_20261103_121408879.xml)
- [Narayana Hrudayalaya Ltd. has informed the Exchange about Investor Presentation |SUBJECT: Investor Presentation](https://nsearchives.nseindia.com/corporate/Narayana_02112026131159_NHLRevisedIRNov022026.pdf)
- [Narayana Hrudayalaya Ltd. has informed the Exchange about Audio Recording of Earnings Call for the quarter and half year ended September 30, 2026 |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates](https://nsearchives.nseindia.com/corporate/Narayana_02112026174957_SEAudioRecordingQ2EarningsCall02112026.pdf)
- [Narayana Hrudayalaya Ltd. has informed the Exchange about Copy of Newspaper Publication for un-audited (Standalone and Consolidated) Financial Results forthe quarter and half year ended September 30, 2026 |SUBJECT: Copy of Newspaper Publication](https://nsearchives.nseindia.com/corporate/Narayana_01112026213626_NHL_Newspaper_Publicat.pdf)
- [Narayana Hrudayalaya Ltd. has submitted to the Exchange, the financial results for the quarter and half-year ended September 30, 2026. |SUBJECT: Outcome of Board Meeting](https://nsearchives.nseindia.com/corporate/Narayana_30102026184850_OutcomeofBMOctober302026NHL.pdf)
- [Narayana Hrudayalaya Ltd. has informed the Exchange regarding a press release dated October 30, 2026, titled "Narayana Hrudayalaya Limited announces Q2 FY27 results". |SUBJECT: Press Release](https://nsearchives.nseindia.com/corporate/Narayana_30102026185357_SEPressreleaseOct30NHL.pdf)
- [Narayana Hrudayalaya Ltd. has informed the Exchange about Investor Presentation |SUBJECT: Investor Presentation](https://nsearchives.nseindia.com/corporate/Narayana_30102026185651_SENHLInvestorPresentationOct_302026NHL.pdf)

### Fundamentals

Narayana Hrudayalaya (NH) is executing a rapid expansion phase, evidenced by a 73% year-on-year sales jump to ₹2,844 crore in Q2 FY2026-27 and total assets growing from ₹7,742 crore to ₹13,367 crore over the trailing twelve months. This growth is capital-intensive; borrowings rose sharply to ₹6,075 crore as of September 2026, driving finance costs up to ₹96.7 crore in the latest quarter. Despite higher interest expenses, operating profit expanded robustly to ₹551 crore, supporting a net profit increase to ₹301 crore and EPS growth to ₹14.73.

Earnings quality remains strong, with cash flow from operations converting 108% of operating profit into cash for the year ended March 2026. However, the aggressive balance-sheet expansion has compressed Return on Capital Employed (ROCE) from 26% in March 2024 to 16% in March 2026, reflecting the lag between new asset deployment and full profitability. The company’s working capital cycle remains negative (-176 days), indicating efficient cash conversion relative to payables. Institutional investors are adjusting positions, with DIIs increasing their stake to 10.68% while promoters slightly diluted theirs to 63.27%.

- Revenue surged 73% YoY to ₹2,844 crore in Q2 FY2026-27, with sequential revenue growth confirming an active expansion trajectory.
- Borrowings increased to ₹6,075 crore (Sep 2026) and ROCE declined to 16%, signaling that recent capex is diluting near-term capital efficiency.
- Cash conversion remains robust at 108% of operating profit (FY2026), providing internal liquidity despite rising finance costs of ₹96.7 crore.
- Next checkpoint: Monitor whether operating margins sustain as new assets transition from CWIP to fixed assets and begin contributing fully to earnings.

### Bear Case

Narayana Hrudayalaya (NSE: NH) presents a mixed technical setup as of 6 November 2026, with near-term momentum diverging from longer-term trends. While the daily chart shows a bullish super-trend and positive slope indicators, the weekly and monthly timeframes are bearish, suggesting underlying structural weakness or consolidation. The stock is trading at ₹1902.10, down 0.7% for the day, with immediate resistance at ₹1926.10 (pivot) and ₹1942.30 (high). A breach below the nearest support levels at ₹1899.30 and ₹1896.39 could expose further downside toward ₹1883.10.

Volatility remains elevated, with an annualized volatility of +32.2% and an average true range (ATR) of 2.91%, indicating significant price swings. The stock has experienced a current drawdown of -16.0% from its peak, with a maximum historical drawdown of -29.1%. Year-to-date performance is negative at -1.7%, despite a strong return since inception (+44.9%). These factors highlight the need for caution regarding entry timing and risk management in a volatile environment.

- Technical divergence: Daily trend is bullish, but weekly and monthly super-trends are bearish, signaling potential short-term reversal or consolidation pressure.
- Key resistance levels: Immediate pivot resistance at ₹1926.10 (+1.26%) and high resistance at ₹1942.30 (+2.11%) may cap upside if buying interest wanes.
- Support vulnerability: Close support exists at ₹1899.30 (-0.15%) and ₹1896.39 (-0.30%); a break below these could trigger moves toward ₹1883.10 (-1.00%).
- Elevated volatility and drawdown: Annualized volatility stands at +32.2% with a current drawdown of -16.0%, reflecting heightened price risk compared to broader market averages.

- [Buy Narayana Hrudayalaya; target of Rs 2350: Prabhudas Lilladher](https://www.moneycontrol.com/news/business/stocks/buy-narayana-hrudayalaya-target-of-rs-2350-prabhudas-lilladher-2-14067611.html)
- [Narayana Hrudayalaya Ltd. has informed the Exchange regarding 'Conferment of the French National Order of Merit on Dr. Devi Prasad Shetty, Founder and Chairman'. |SUBJECT: Updates](https://nsearchives.nseindia.com/corporate/Narayana_05112026202146_SENHLRecognition_to_DrShetty_05112026.pdf)
- [Narayana Hrudayalaya Ltd. has informed the Exchange about Filing of the Orderof the Hon ble National Company Law Tribunal, Bengaluru Bench sanctioning the Scheme ofArrangement between NH Integrated Care Private Limited (WOS) and NarayanaHrudayalaya Limited |SUBJECT: Demerger](https://nsearchives.nseindia.com/corporate/Narayana_04112026222839_SE-Order_-NHIC_Demerger.pdf)
- [Narayana Hrudayalaya Ltd. has informed the Exchange about Schedule of Analysts or Institutional Investors Meet |SUBJECT: Analyst/Investor Meet Para A-XBRL](https://nsearchives.nseindia.com/corporate/xbrl/SAIIM_13340_WebXMLFile_20261103_121255291.xml)
- [Narayana Hrudayalaya Ltd. has informed the Exchange about Audio Recording/Video Recording |SUBJECT: Analyst/Investor Meet Para A-XBRL](https://nsearchives.nseindia.com/corporate/xbrl/SAIIM_13340_WebXMLFile_20261103_121408879.xml)
- [Narayana Hrudayalaya Ltd. has informed the Exchange about Investor Presentation |SUBJECT: Investor Presentation](https://nsearchives.nseindia.com/corporate/Narayana_02112026131159_NHLRevisedIRNov022026.pdf)
- [Narayana Hrudayalaya Ltd. has informed the Exchange about Audio Recording of Earnings Call for the quarter and half year ended September 30, 2026 |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates](https://nsearchives.nseindia.com/corporate/Narayana_02112026174957_SEAudioRecordingQ2EarningsCall02112026.pdf)
- [Narayana Hrudayalaya Ltd. has informed the Exchange about Copy of Newspaper Publication for un-audited (Standalone and Consolidated) Financial Results forthe quarter and half year ended September 30, 2026 |SUBJECT: Copy of Newspaper Publication](https://nsearchives.nseindia.com/corporate/Narayana_01112026213626_NHL_Newspaper_Publicat.pdf)
- [Narayana Hrudayalaya Ltd. has submitted to the Exchange, the financial results for the quarter and half-year ended September 30, 2026. |SUBJECT: Outcome of Board Meeting](https://nsearchives.nseindia.com/corporate/Narayana_30102026184850_OutcomeofBMOctober302026NHL.pdf)
- [Narayana Hrudayalaya Ltd. has informed the Exchange regarding a press release dated October 30, 2026, titled "Narayana Hrudayalaya Limited announces Q2 FY27 results". |SUBJECT: Press Release](https://nsearchives.nseindia.com/corporate/Narayana_30102026185357_SEPressreleaseOct30NHL.pdf)

### FAQs

**What are the latest financial results and operational updates for Narayana Hrudayalaya?**

For Q2 FY27 (ended September 30, 2026), consolidated operating revenues rose +73.0% YoY to ₹28,440 Mn, while PAT increased +16.6% YoY to ₹3,012 Mn. Net debt stands at ₹18,830 Mn with a net debt-to-equity ratio of 0.38. The company commenced operations at Banashankari Hospital and Nagarabhavi Clinic in late September 2026.

**What is the status of the demerger involving NH Integrated Care Private Limited?**

The NCLT Bengaluru Bench approved the scheme on October 30, 2026, to demerge Clinical Services from its wholly owned subsidiary into the parent company, with an appointed date of April 1, 2025. As of November 4, 2026, certified copies were awaited; no shares will be issued, and there is no change to share capital or shareholding pattern.

**How has the stock performed technically over recent periods?**

As of November 6, 2026, the stock closed at ₹1902.1, down -0.7% intraday. It is up +15.5% over 10 days and +10.3% over one month, but YTD returns are -1.7%. Daily technical indicators show a bullish Supertrend, while monthly and weekly trends remain bearish. The stock is currently trading within a support range of ₹1883.1–₹1899.3 and resistance levels of ₹1926.1–₹1946.2.

- [Buy Narayana Hrudayalaya; target of Rs 2350: Prabhudas Lilladher](https://www.moneycontrol.com/news/business/stocks/buy-narayana-hrudayalaya-target-of-rs-2350-prabhudas-lilladher-2-14067611.html)
- [Narayana Hrudayalaya Ltd. has informed the Exchange regarding 'Conferment of the French National Order of Merit on Dr. Devi Prasad Shetty, Founder and Chairman'. |SUBJECT: Updates](https://nsearchives.nseindia.com/corporate/Narayana_05112026202146_SENHLRecognition_to_DrShetty_05112026.pdf)
- [Narayana Hrudayalaya Ltd. has informed the Exchange about Filing of the Orderof the Hon ble National Company Law Tribunal, Bengaluru Bench sanctioning the Scheme ofArrangement between NH Integrated Care Private Limited (WOS) and NarayanaHrudayalaya Limited |SUBJECT: Demerger](https://nsearchives.nseindia.com/corporate/Narayana_04112026222839_SE-Order_-NHIC_Demerger.pdf)
- [Narayana Hrudayalaya Ltd. has informed the Exchange about Schedule of Analysts or Institutional Investors Meet |SUBJECT: Analyst/Investor Meet Para A-XBRL](https://nsearchives.nseindia.com/corporate/xbrl/SAIIM_13340_WebXMLFile_20261103_121255291.xml)
- [Narayana Hrudayalaya Ltd. has informed the Exchange about Audio Recording/Video Recording |SUBJECT: Analyst/Investor Meet Para A-XBRL](https://nsearchives.nseindia.com/corporate/xbrl/SAIIM_13340_WebXMLFile_20261103_121408879.xml)
- [Narayana Hrudayalaya Ltd. has informed the Exchange about Investor Presentation |SUBJECT: Investor Presentation](https://nsearchives.nseindia.com/corporate/Narayana_02112026131159_NHLRevisedIRNov022026.pdf)
- [Narayana Hrudayalaya Ltd. has informed the Exchange about Audio Recording of Earnings Call for the quarter and half year ended September 30, 2026 |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates](https://nsearchives.nseindia.com/corporate/Narayana_02112026174957_SEAudioRecordingQ2EarningsCall02112026.pdf)
- [Narayana Hrudayalaya Ltd. has informed the Exchange about Copy of Newspaper Publication for un-audited (Standalone and Consolidated) Financial Results forthe quarter and half year ended September 30, 2026 |SUBJECT: Copy of Newspaper Publication](https://nsearchives.nseindia.com/corporate/Narayana_01112026213626_NHL_Newspaper_Publicat.pdf)
- [Narayana Hrudayalaya Ltd. has submitted to the Exchange, the financial results for the quarter and half-year ended September 30, 2026. |SUBJECT: Outcome of Board Meeting](https://nsearchives.nseindia.com/corporate/Narayana_30102026184850_OutcomeofBMOctober302026NHL.pdf)
- [Narayana Hrudayalaya Ltd. has informed the Exchange regarding a press release dated October 30, 2026, titled "Narayana Hrudayalaya Limited announces Q2 FY27 results". |SUBJECT: Press Release](https://nsearchives.nseindia.com/corporate/Narayana_30102026185357_SEPressreleaseOct30NHL.pdf)
## Technical analytics

- As of: 2026-11-06
- Daily trend: Weak Uptrend
- Weekly trend: Moderate Uptrend
- Pivot point: ₹1,926.1
- Risk regime: Price Risk Requires Attention

### Support levels
- 1896.3875
- 1830.85
- 1772.8

### Resistance levels
- 1946.2025390625
- 2016.1
- 2056.2875

### Return and range metrics

| Metric | Value |
| --- | --- |
| return_1 | -0.70% |
| return_10 | +15.50% |
| return_1m | +10.34% |
| return_1y | +4.52% |
| return_20 | +12.20% |
| return_3m | +0.91% |
| return_5 | +10.57% |
| return_6m | +3.35% |
| return_since_start | +44.92% |
| return_ytd | -1.67% |

### Risk and volatility metrics

| Metric | Value |
| --- | --- |
| state | elevated_risk |
| label | Price risk requires attention |
| summary | Recent drawdown or price variability is high enough to warrant closer monitoring. |
| maximum_drawdown | -29.07% |
| annualized_volatility | +32.21% |

## Quarterly financials

- Latest complete quarter: fy27_q2

# Narayana Hrudayalaya Ltd. Q2 FY2026-27: Pre-tax profit rises 31% QoQ

Consolidated revenue from operations rose 6.0% sequentially and 73.0% year on year to ₹2,844 crore in Q2 FY2026-27. Profit before tax increased 30.9% QoQ to ₹343 crore, while profit for the period rose 45.3% to ₹301 crore. Expenses grew more slowly than revenue, though finance costs increased and cash was lower than at 31 March 2026.

## Revenue growth outpaces expense growth

Revenue from operations increased from ₹2,684 crore in Q1 FY2026-27 to ₹2,844 crore in Q2. Expenses rose 3.8% QoQ to ₹2,550 crore, below the 6.0% increase in revenue. Profit before exceptional items and tax advanced 31.8% to ₹346 crore from ₹262 crore in Q1.

Revenue from operations has risen in each of the past four quarters, from ₹2,151 crore in Q3 FY2025-26 to ₹2,844 crore in Q2 FY2026-27. Compared with Q2 FY2025-26, revenue increased 73.0%, while expenses rose 86.0%.

Segment revenue from operations was ₹2,896 crore, up 6.5% QoQ, and segment profit before tax rose 31.9% to ₹343 crore.

## Lower tax supports sequential profit growth; finance costs rise

Finance costs increased 11.4% QoQ to ₹97 crore from ₹87 crore in Q1 FY2026-27. Tax expense declined 20.6% to ₹42 crore from ₹53 crore. Profit for the period rose to ₹301 crore from ₹207 crore in Q1.

## Balance sheet grows; cash falls from March level

Total assets were ₹13,367 crore at 30 September 2026, compared with ₹12,474 crore at 31 March 2026 and ₹7,742 crore at 30 September 2025. Equity stood at ₹5,005 crore, up from ₹4,540 crore at 31 March 2026.

Noncurrent borrowings were ₹4,698 crore at quarter-end, compared with ₹4,667 crore at 31 March 2026 and ₹1,931 crore a year earlier. Current liabilities increased to ₹2,130 crore. Trade payables rose to ₹1,198 crore from ₹1,032 crore at 31 March 2026, while trade receivables increased to ₹962 crore from ₹656 crore.

Cash and cash equivalents were ₹497 crore, down from ₹770 crore at 31 March 2026. Property, plant and equipment stood at ₹4,641 crore, compared with ₹4,527 crore at 31 March 2026 and ₹3,947 crore at 30 September 2025.

## Management Commentary

Management reported consolidated operating revenue of ₹28,440 million in Q2 FY27, up 6.0% QoQ and 73.0% YoY, and EBITDA of ₹6,054 million at a 21.3% margin. The network comprised 56 healthcare facilities, 6,119 operational beds and about 21,150 staff at quarter-end. Narayana Institute of Cardiac Sciences performed 54 TAVIs and six hybrid percutaneous pulmonary valve implantations during the quarter. Banashankari Hospital and Nagarabhavi Clinic began operations in the last week of September 2026; management said their operating metrics would be reflected from Q3 FY27.

## Key Takeaway

Q2 delivered strong sequential profit growth as revenue rose faster than expenses, while lower tax expense also supported the increase in profit for the period. The balance sheet expanded, but cash declined from the March closing level and finance costs rose.

### Ratios

## Shareholding pattern

- Quarter: FY2027-Q2
- As of: 2026-09-30
- Promoter holding: +63.27%
- FII holding: +9.01%
- DII holding: +10.68%
- Mutual fund holding: +8.64%
- Retail holding: +8.19%
- Promoter pledged: +0.00%

### Major reported shareholders

- SHAKUNTALA SHETTY — +34.80%
- DEVI PRASAD SHETTY — +11.66%
- VIREN PRASAD SHETTY — +5.00%
- VARUN SHETTY — +5.00%
- ANESH SHETTY — +5.00%
- MIRAE ASSET LARGE & MIDCAP FUND — +4.54%
- KIRAN MAZUMDAR SHAW — +2.30%
- NARAYANA HEALTH ACADEMY PVT LTD — +1.81% (Bodies Corporate)
- RENUKA MUKESH JAGTIANI — +1.29%
- PARAG PARIKH FLEXI CAP FUND — +1.03%

## Official filings

- 2026-11-07 — Generic Announcement: Narayana Hrudayalaya Ltd. — [Official attachment](https://nsearchives.nseindia.com/corporate/Narayana_07112026140347_SE_Transcript_Nov_02_2026.pdf)
- 2026-11-07 — Generic Announcement: Narayana Hrudayalaya Ltd. — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/SAIIM_13340_WebXMLFile_20261107_141256981.xml)
- 2026-11-05 — Generic Announcement: Narayana Hrudayalaya Ltd. — [Official attachment](https://nsearchives.nseindia.com/corporate/Narayana_05112026202146_SENHLRecognition_to_DrShetty_05112026.pdf)
- 2026-11-04 — Generic Announcement: Narayana Hrudayalaya Ltd. — [Official attachment](https://nsearchives.nseindia.com/corporate/Narayana_04112026222839_SE-Order_-NHIC_Demerger.pdf)
- 2026-11-03 — Generic Announcement: Narayana Hrudayalaya Ltd. — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/SAIIM_13340_WebXMLFile_20261103_121255291.xml)
- 2026-11-03 — Generic Announcement: Narayana Hrudayalaya Ltd. — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/SAIIM_13340_WebXMLFile_20261103_121408879.xml)
- 2026-11-02 — Earnings Presentation: Narayana Hrudayalaya Ltd. — [Official attachment](https://nsearchives.nseindia.com/corporate/Narayana_02112026131159_NHLRevisedIRNov022026.pdf)
- 2026-11-02 — Generic Announcement: Narayana Hrudayalaya Ltd. — [Official attachment](https://nsearchives.nseindia.com/corporate/Narayana_02112026174957_SEAudioRecordingQ2EarningsCall02112026.pdf)
- 2026-11-01 — Generic Announcement: Narayana Hrudayalaya Ltd. — [Official attachment](https://nsearchives.nseindia.com/corporate/Narayana_01112026213626_NHL_Newspaper_Publicat.pdf)
- 2026-10-30 — Generic Announcement: Narayana Hrudayalaya Ltd. — [Official attachment](https://nsearchives.nseindia.com/corporate/Narayana_30102026184850_OutcomeofBMOctober302026NHL.pdf)
- 2026-10-30 — Press Release: Narayana Hrudayalaya Ltd. — [Official attachment](https://nsearchives.nseindia.com/corporate/Narayana_30102026185357_SEPressreleaseOct30NHL.pdf)
- 2026-10-30 — Earnings Presentation: Narayana Hrudayalaya Ltd. — [Official attachment](https://nsearchives.nseindia.com/corporate/Narayana_30102026185651_SENHLInvestorPresentationOct_302026NHL.pdf)
- 2026-10-30 — Management Change: Narayana Hrudayalaya Ltd. — [Official attachment](https://nsearchives.nseindia.com/corporate/Narayana_30102026190054_SEIntimationAppointmentofStatutoryAuditors30102026NHL.pdf)
- 2026-10-30 — Generic Announcement: Narayana Hrudayalaya Ltd. — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/CIM_13340_WebXMLFile_20261030_190315934.xml)
- 2026-10-30 — Financial Results Filing: Narayana Hrudayalaya Ltd. — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1750508_30102026085540_WEB.xml)
- 2026-10-30 — Financial Results Filing: Narayana Hrudayalaya Ltd. — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1750509_30102026085546_WEB.xml)
- 2026-10-26 — Board Meeting Notice: Narayana Hrudayalaya Ltd. — [Official attachment](https://nsearchives.nseindia.com/corporate/Narayana_26102026203128_SE-_Board_meeting_Intimation.pdf)
- 2026-10-26 — Generic Announcement: Narayana Hrudayalaya Ltd. — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/PRIOR_INTIMATION_13340_WebXMLFile_20261026_203826798.xml)
- 2026-10-26 — Board Meeting Notice: Narayana Hrudayalaya Ltd. — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/PRIOR_INTIMATION_13340_WebXMLFile_20261026_203826798.xml)
- 2026-10-26 — Generic Announcement: Narayana Hrudayalaya Ltd. — [Official attachment](https://nsearchives.nseindia.com/corporate/Narayana_26102026204455_SE_Investors_meeting_intimation_Nov_022026.pdf)
- 2026-10-26 — Generic Announcement: Narayana Hrudayalaya Ltd. — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/SAIIM_13340_WebXMLFile_20261026_204916550.xml)
- 2026-10-13 — Shareholding Disclosure: Narayana Hrudayalaya Ltd. — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/SHP_1736827_13102026030512_WEB.xml)
- 2026-10-06 — Generic Announcement: Narayana Hrudayalaya Ltd. — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/ANN_AGREEMENT_13340_WebXMLFile_20261006_114049277.xml)
- 2026-10-06 — Generic Announcement: Narayana Hrudayalaya Ltd. — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/REG30_PARA_B_13340_WebXMLFile_20261006_150303422.xml)
- 2026-10-05 — Generic Announcement: Narayana Hrudayalaya Ltd. — [Official attachment](https://nsearchives.nseindia.com/corporate/Narayana_05102026170031_SE_Letter-_Scruntinizer_report_Voting_results.pdf)

## News and market events

- 2026-11-03 — MONEYCONTROL: **Buy Narayana Hrudayalaya; target of Rs 2350: Prabhudas Lilladher** — Prabhudas Lilladher has issued a 'Buy' recommendation for Narayana Hrudayalaya, setting a price target of Rs 2350. This financial advice is reported by Moneycontrol as part of its stock market coverage. — [Source](https://www.moneycontrol.com/news/business/stocks/buy-narayana-hrudayalaya-target-of-rs-2350-prabhudas-lilladher-2-14067611.html)
- 2026-10-30 — CNBC-TV18: **Narayana Hrudayalaya Q2 Results: Net profit surges on higher patient volumes, complex procedures** — Narayana Hrudayalaya Ltd reported Q2 FY27 consolidated revenue rose 73% to ₹2,844 crore and net profit increased 16.5% to ₹301 crore, with underlying India hospital EBITDA margins expanding to 26.8% due to higher patient volumes and complex procedures. — [Source](https://www.cnbctv18.com/market/stocks/narayana-hrudayalaya-share-price-q2-results-net-profit-surges-on-higher-patient-volumes-complex-procedures-20023712.htm)
- 2026-10-06 — The Hindu: **Narayana Hrudayalaya to manage Mission of Mercy Hospital in Kolkata** — Narayana Hrudayalaya has agreed to operate and manage Mission of Mercy Hospital in Kolkata, a 100-bed facility with a built-up area of 63,240.37 sq ft. — [Source](https://www.thehindubusinessline.com/companies/narayana-hrudayalaya-to-operate-and-manage-mission-of-mercy-hospital-in-kolkata/article71549045.ece)
- 2026-10-06 — Economic Times: **Stocks in news: Vedanta, Kotak Mahindra Bank, Marico, Axis Bank, Trent and Zydus Lifesciences** — Indian equity markets showed signs of recovery on Monday after softer-than-expected US jobs data was released. The Nifty 50 index ended the session up, suggesting improved investor confidence. Investors are watching key corporate updates from companies like Vedanta and Kotak Mahindra Bank for future trends. Firms reported various operational advancements and financial performance improvements for the quarter. The overall sentiment in the market remains cautiously optimistic amid external economi... — [Source](https://economictimes.indiatimes.com/markets/stocks/news/stocks-in-news-vedanta-kotak-mahindra-bank-marico-axis-bank-trent-and-zydus-lifesciences/articleshow/134712004.cms)
- 2026-10-05 — CNBC-TV18: **Narayana Hrudayalaya signs agreement to manage 100-bed Mission of Mercy hospital in Kolkata** — Shares of Narayana Hrudayalaya Ltd ended at ₹1,722.00, down by ₹19.85, or 1.14%, on the BSE. — [Source](https://www.cnbctv18.com/market/stocks/narayana-hrudayalaya-share-price-signs-agreement-to-manage-100-bed-mission-of-mercy-hospital-in-kolkata-20004832.htm)
- 2026-09-30 — Economic Times: **Hospital stocks fall up to 6%: Apollo, Fortis, KIMS tumble as SC questions drug mark-ups** — Hospital stocks came under pressure after the Supreme Court raised concerns over steep mark-ups on medicines sold through corporate hospitals. — [Source](https://economictimes.indiatimes.com/markets/stocks/news/hospital-stocks-fall-up-to-6-apollo-fortis-kims-tumble-as-sc-questions-drug-mark-ups/articleshow/134589671.cms)
- 2026-09-09 — MONEYCONTROL: **Trade Spotlight: How should you trade Marico, Narayana Hrudayalaya, Granules, Laurus Labs, Caplin Point, Tata Technologies, and others on September 9?** — Trade Spotlight — [Source](https://www.moneycontrol.com/news/business/markets/trade-spotlight-how-should-you-trade-marico-narayana-hrudayalaya-granules-laurus-labs-caplin-point-tata-technologies-and-others-on-september-9-14025670.html)
- 2026-08-27 — BUSINESSTODAY: **IREDA, Ashok Leyland, SBI, Mazagon Dock, Narayana Hrudayalaya shares: Expert weighs in** — Mazagon Dock Shipbuilders, Narayana Hrudayalaya, IREDA, Ashok Leyland, State Bank of India, SBI shares, stock market, stock picks, Rachit Khandelwal, BNK Capital, Nifty50, stock recommendations — [Source](https://www.businesstoday.in/markets/stocks/story/ireda-ashok-leyland-sbi-mazagon-dock-narayana-hrudayalaya-shares-expert-weighs-in-551721-2026-08-27)
- 2026-08-25 — MONEYCONTROL: **Trade Spotlight: How should you trade Balaji Amines, Cochin Shipyard, United Spirits, Siemens, Muthoot Finance, PTC Industries, and others on August 25?** — Trade Spotlight, Buy Ideas,Top Buy Ideas,Top Picks,Stock Picks,Top Stock Picks,Share Tips,Share Market Tips,Stock Tips,Stock Market Tips,Narayana Hrudayalaya,Balaji Amines,Axis Bank,Cochin Shipyard,Tata Steel,Bank of India,United Spirits,Siemens,Chalet Hotels,Muthoot Finance,PTC Industries, — [Source](https://www.moneycontrol.com/news/business/markets/trade-spotlight-how-should-you-trade-balaji-amines-cochin-shipyard-united-spirits-siemens-muthoot-finance-ptc-industries-and-others-on-august-25-14014535.html)
- 2026-08-24 — CNBC-TV18: **Stocks To Buy: Kotak upgrades this healthcare stock with nearly 30% upside** — Kotak Institutional Equities has upgraded Narayana Hrudayalaya to ‘Buy’ with a target price of ₹2,350, implying nearly 29% upside from Friday’s close, citing strong hospital growth and improving prospects for its insurance businesses. — [Source](https://www.cnbctv18.com/market/stocks-to-buy-kotak-upgrades-narayana-hrudayalaya-with-nearly-30-pc-upside-19975653.htm)
- 2026-08-24 — BUSINESSTODAY: **UBS target lifts Apollo Tyres shares; Narayana Hrudayalaya rise after HSBC rating upgrade** — Apollo Tyres share price, Narayana Hrudayalaya share price, Apollo Tyres shares, Narayana Hrudayalaya shares — [Source](https://www.businesstoday.in/markets/stocks/story/ubs-target-lifts-apollo-tyres-shares-narayana-hrudayalaya-rise-after-hsbc-rating-upgrade-550892-2026-08-24)
- 2026-08-16 — Economic Times: **In private healthcare's rise, price points are a big pain** — In a recent proposal, a parliamentary committee has recommended that hospital room charges not exceed the rates of three-star hotels. The substantial growth of private healthcare as an industry has attracted considerable private equity investment, resulting in valuation spikes and shifts in ownership among hospital chains. However, this raises important questions about the accessibility of healthcare for the average person. — [Source](https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/in-private-healthcares-rise-price-points-are-a-big-pain/articleshow/133281484.cms)
- 2026-08-11 — BUSINESS: **Kotak Securities' top trading bets: Narayana Hrudayalaya, Mrs Bectors Food** — Shrikant Chouhan of Kotak Securities has recommended Narayana Hrudayalaya and Mrs Bectors Food Specialities as top picks for today. — [Source](https://www.business-standard.com/markets/news/kotak-securities-top-trading-bets-narayana-hrudayalaya-mrs-bectors-food-126081100092_1.html)
- 2026-07-30 — Economic Times: **Can Manipal Health IPO deliver long-term growth for high risk investors?** — Manipal Health Enterprises plans to raise ₹8,000 crore through a fresh issue for debt repayment and expansion. The company's revenue grew strongly in recent years, while margins faced pressure. Its occupancy rate declined, and geographic concentration is noted in Karnataka. The promoter group's stake will decrease after the initial public offering. Investors may consider waiting for post-listing clarity due to aggressive pricing. — [Source](https://economictimes.indiatimes.com/markets/ipos/fpos/can-manipal-health-ipo-deliver-long-term-growth-for-high-risk-investors/articleshow/132724295.cms)

## Business profile

**Strategic vision:** Delivering healthcare through technology and patient-centricity.

### Business segments
- **Hospital and Clinic Operations:** Operates a network of hospitals and clinics providing care across various specialties, including cardiology, multispeciality, and superspeciality services.

### Competitive strengths
- Advanced technology
- Trusted brand
- Skilled personnel
- Operational discipline
- Compassion

## Related stocks

- [Abbott India Limited (Healthcare)](https://faxioms.com/stocks/abbotindia) — -0.85%
- [Acutaas Chemicals Limited (Healthcare)](https://faxioms.com/stocks/acutaas) — +0.30%
- [Ajanta Pharma Limited (Healthcare)](https://faxioms.com/stocks/ajantpharm) — +0.55%
- [Alkem Laboratories Limited (Healthcare)](https://faxioms.com/stocks/alkem) — +2.06%
- [Anthem Biosciences Limited (Healthcare)](https://faxioms.com/stocks/anthem) — +0.16%

## Freshness and sources

- Data as of: 2026-11-06
- Source: Faxioms public stock analysis API

Canonical: https://faxioms.com/stocks/nh
Markdown representation: https://faxioms.com/stocks/nh?render=md